Unlock instant, AI-driven research and patent intelligence for your innovation.

Compositions and methods for preventing influenza infection in canines, felines and equines

A composition, a technology for canine influenza, applied in the field of respiratory diseases of cats or horses, and the treatment of dogs, which can solve problems such as use limitations

Inactive Publication Date: 2010-08-11
INTERVET INT BV
View PDF17 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0023] To date, the use of NDV viruses encoding influenza genes has been limited because influenza genes are derived from H1-, H5- or H7-subtype influenza A hemagglutinin genes
Furthermore, the use of such recombinant negative-strand viruses has been limited and focused on the protection of poultry or primates against avian influenza

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for preventing influenza infection in canines, felines and equines
  • Compositions and methods for preventing influenza infection in canines, felines and equines

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0036] The preparation of such a transcription cassette and its insertion into the MV viral genome involves only conventional molecular biology techniques, as exemplified in International Patent Application PCT / US07 / 64046 and US Patent Application 60 / 783,194. In particular, techniques such as site-directed mutagenesis and PCR mutagenesis can be used for this purpose. More particularly, recombinant MV viral vectors according to the present invention can be prepared by the well-established "reverse genetics" approach, which enables genetic modification of unsegmented, negative-strand RNA viruses of MV order, as described in U.S. Patent 6,033,886, which is hereby incorporated by reference in its entirety.

[0037] In this method, under conditions sufficient to allow the transcription and co-expression of the MV (anti)genome and supporting proteins, and the production of recombinant MV vectors, by containing nucleosides encoding the full-length genome or, preferably, the antigenom...

Embodiment 1

[0072] Example 1. Construction of recombinant NDV expressing canine influenza hemagglutinin gene

[0073] A. Preparation of DNA encoding influenza hemagglutinin (HA)

[0074] Influenza HA inserts were obtained by reverse transcriptase polymerase chain reaction (RT-PCR) using the Access RT-PCR System Kit (Promega Corporation, Madison, WI). exist On a microprocessor-controlled robotic thermocycler (Stratagene, Santa Clara, California), using Tf1 DNA polymerase from the kit, virus isolate A / canine / Jacksonville / 05 (also known as canine / Jax / 05, Accession No. PTA-7941, American Type Culture Collection (ATCC), 10801 University Blvd, Manassas, VA 20110-2209), using hemagglutinin-specific primers (5'-acggcaatcgATGAAGACAACCATTATTTTGA-3') and (5'-acggcagcgcgcTCAAATGCAAATGTTGCATC -3') to amplify the HA insert.

[0075] The amplified HA sequence was separated and separated from the other components of the PCR mixture on an electrophoretic gel. According to the manufacturer's instructi...

Embodiment 2

[0090] Example 2. Efficacy Study of Canine Influenza Vaccine

[0091] In the following study, a method of protecting dogs against respiratory infections involving the administration of a recombinant single-stranded negative-strand virus with a heterologous respiratory virus nucleotide sequence was investigated.

[0092] Recombinant viruses were passaged in eggs a total of seven times, and allantoic fluid was collected. EID was determined by inoculating 200 μl of 10-fold serial dilutions of P7 allantoic fluid into 10 embryonated 10-day-old eggs / dilution 50 titer. Five days after inoculation, the allantoic fluid was tested for coagulation. Calculate EID 50 titer. Dilute the allantoic fluid 10-fold in sterile phosphate-buffered saline to an appropriate 10 8 Virus / ml titers were used to prepare vaccines, aliquoted and frozen.

[0093] Each dose of the vaccine contains 10 8 EID 50 And enough PBS was added to bring the total dose volume to 1 ml.

[0094] Fifteen female beag...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is directed to the use of recombinant, chimeric mononegavirale vectors comprising a foreign gene. More particularly, the present invention is directed to the use of such vectors for treating respiratory diseases in canines, felines or equines. An embodiment of the present invention is the use of a recombinant Newcastle disease virus vector comprising a hemagglutinin from an H3N8 influenza in the protection or treatment of canines, equines or felines against influenza.

Description

field of invention [0001] The present invention relates to the use of recombinant, chimeric single-strand negative-strand virus (mononegavirale) vectors containing foreign genes. More particularly, the invention relates to the use of such vectors for the treatment of respiratory diseases in dogs, cats or horses. Background of the invention [0002] Live viruses capable of replicating in infected hosts induce strong and long-lasting immune responses against the antigens they express. They are effective in eliciting both humoral- and cell-mediated immune responses and in stimulating cytokine and chemokine pathways. Thus, live, attenuated viruses offer distinct advantages over vaccine compositions based on inactivated or subunit immunogens, which typically stimulate only the humoral humors of the immune system to a large extent branch part. [0003] Over the past decade, recombinant DNA technology has revolutionized the field of genetic engineering of DNA and RNA viral genom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/145C12N15/86A61K39/00
CPCC12N2760/18143A61K39/145A61K2039/543A61K2039/5256A61K2039/552C12N2760/16134C12N15/86A61K39/12A61P31/16A61P37/04A61P43/00
Inventor T·梅巴齐翁J·莫里P·R·林兹
Owner INTERVET INT BV